Edition:
United Kingdom

People: Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

6.78EUR
4:35pm BST
Change (% chg)

€-0.26 (-3.69%)
Prev Close
€7.04
Open
€7.00
Day's High
€7.03
Day's Low
€6.75
Volume
88,786
Avg. Vol
138,652
52-wk High
€9.18
52-wk Low
€4.92

Sato, Kumi 

Ms. Kumi Sato has served as Independent Director of the Company since June 30, 2017. She is Member of company's Business Development Committee. For over 30 years, Kumi Sato has served as President and CEO of Cosmo Public Relations Corporation, an award-winning strategic communications and public affairs firm based in Tokyo, Japan, with a specialized healthcare division, COSMO Healthcare. Since its founding, COSMO has consulted for over 500 companies in healthcare, food and food sciences, and the service industry. Before taking over as CEO in 1987, she founded COSMO International, which advised Japanese companies on US market entry strategies. During her time at COSMO, she has been instrumental in directing the company to broaden its international focus and has held a series of noteworthy advisor positions, such as President and Founder of Women Japan.com and Outside Director for Rokko & Associates Inc. In 2010, she founded BioCube, a think-tank to discuss Japan's healthcare system and biotech-related topics. She currently serves as an advisor to the Global Health Innovative Technology Fund in Tokyo, a lecturer at the Graduate School of Business Breakthrough University and is Chairman Emeritus of the American Chamber of Commerce in Japan. In addition, she is co-chairman of the Global Council for the Asia Society, based in New York. Ms. Sato has also authored two business textbooks on communication strategies and corporate social responsibility. Ms. Sato started her career at McKinsey & Co., New York and holds a B.A. in East Asian Studies from Wellesley College, MA.

Basic Compensation

Total Annual Compensation, EUR --
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 114,846
Fiscal Year Total, EUR 114,846

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --